Richard Aranda - 24 Jun 2024 Form 4 Insider Report for Gossamer Bio, Inc. (GOSS)

Role
Chief Medical Officer
Signature
/s/ Jeff Boerneke, Attorney-in-Fact
Issuer symbol
GOSS
Transactions as of
24 Jun 2024
Net transactions value
-$1,260
Form type
4
Filing time
25 Jun 2024, 18:24:48 UTC
Previous filing
19 Mar 2024
Next filing
06 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GOSS Common Stock Sale $1,260 -1,908 -0.96% $0.6605 196,891 24 Jun 2024 Direct F1
holding GOSS Common Stock 2,539 24 Jun 2024 By family trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units.